Notice Number: NOT-DA-13-013
Release Date: January 17, 2013
National Institute on Drug Abuse (NIDA)
This Notice issued by the National Institute on Drug Abuse is to clarify the placement of the "Certification of Eligibility" in applications submitted for PAR-11-060 "Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)".
PAR-11-060 instructs applicants to place the “Certification of Eligibility” as page #1 then the “Face Page” as page #2. Applicants are now being advised to place the Face Page as page #1 and “Certification of Eligibility” as page #2.
Section IV.6. Other Submission Requirements of the FOA should be revised to state:
Applications should be organized as follows.
Certification of Eligibility
Description, Project/Performance Sites, Senior/Key Personnel, Other Significant Contributors, and Human Embryonic Stem CellsAll other aspects of this FOA remain the same.
Please direct all inquiries to:
Special Populations Office
National Institute on Drug Abuse
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
NIH . . . Turning Discovery Into Health